|
Market Closed -
Hong Kong S.E.
09:08:09 02/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 34.64 HKD | -5.20% |
|
+14.02% | -0.80% |
| 08-27 | CanSino Biologics Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-26 | CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines | MT |
| Market Cap | 15.67B 18.33B 2.34B 2.08B 1.94B 1.77B 3.33B 225B 3.36B 23.45B 9.09B 115B 8.77B 8.58B 369B | P/E 2026 * |
67.9x | P/E 2027 * | 22.8x |
|---|---|---|---|---|---|
| Enterprise Value | 15.69B 18.36B 2.34B 2.08B 1.94B 1.77B 3.34B 225B 3.37B 23.48B 9.1B 115B 8.79B 8.6B 369B | EV / Sales 2026 * |
10.9x | EV / Sales 2027 * | 8.87x |
| Free-Float |
39.57% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 6185 | Delayed | |
OTC Markets
| CASBF | Delayed | |
|
Boerse Muenchen
| CJH | Real-time | |
|
Tradegate
| CJH | Real-time | |
|
Börse Stuttgart
| CJH | Delayed | |
|
Deutsche Boerse AG
| CJH | Delayed |
| 1 day | -5.20% | ||
| 1 week | +14.02% | ||
| Current month | -5.20% | ||
| 1 month | +17.82% | ||
| 3 months | +42.32% | ||
| 6 months | +4.84% | ||
| Current year | -0.80% |
| 1 week | 30.58 |  | 37.84 |
| 1 month | 25.08 | | 37.84 |
| Current year | 19.22 | | 41.64 |
| 1 year | 19.22 | | 52.2 |
| 3 years | 14.8 | | 56.55 |
| 5 years | 14.8 | | 238.8 |
| 10 years | 14.8 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dong Xu Qiu
PRN | Corporate Officer/Principal | 66 | 20/02/2024 |
Tao Zhu
CTO | Chief Tech/Sci/R&D Officer | 53 | 12/01/2009 |
Xue Feng Yu
CEO | Chief Executive Officer | 62 | 12/01/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Xue Feng Yu
CHM | Chairman | 62 | 12/01/2009 |
Shou Bai Chao
BRD | Director/Board Member | 63 | 21/06/2018 |
Jing Wang
BRD | Director/Board Member | 44 | 10/10/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 26/08/25 | Sell | Director | 4,600 | 0.0069% | ||
| 26/09/24 | Other | Chief Executive Officer | 20,000 | 0.0151% | ||
| 09/09/24 | Other | Founder | 30,000 | 0.0226% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.20% | +14.02% | -33.51% | +56.04% | 2.34B | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +20.54% | +40.33% | 333B | |
| -1.46% | -2.89% | +10.57% | +26.54% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.82% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -1.20% | -1.65% | +20.11% | +58.62% | 369.95B | |
| Weighted average by Cap. | -0.60% | -3.31% | +29.03% | +71.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.44B 1.69B 215M 191M 178M 162M 306M 20.65B 309M 2.16B 835M 10.56B 807M 789M 33.88B | 1.81B 2.12B 270M 240M 224M 204M 385M 25.98B 389M 2.71B 1.05B 13.28B 1.01B 993M 42.63B |
| Net income | 107M 125M 15.96M 14.18M 13.23M 12.06M 22.75M 1.53B 22.96M 160M 62.06M 784M 59.92M 58.62M 2.52B | 322M 377M 48.06M 42.7M 39.85M 36.33M 68.51M 4.62B 69.15M 482M 187M 2.36B 180M 177M 7.58B |
| Net Debt | 24.02M 28.11M 3.58M 3.18M 2.97M 2.71M 5.11M 344M 5.15M 35.95M 13.93M 176M 13.45M 13.16M 565M | 415M 486M 61.91M 55.01M 51.34M 46.8M 88.26M 5.95B 89.08M 621M 241M 3.04B 232M 227M 9.76B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | HK$34.64 | -5.20% | 900,200 |
| 30/09/26 | HK$36.54 | +17.49% | 20,603,303 |
| 29/09/26 | HK$31.10 | -3.30% | 4,289,400 |
| 28/09/26 | HK$32.16 | +5.86% | 8,571,600 |
| 25/09/26 | HK$30.38 | +1.81% | 580,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6185 Stock
Select your edition
All financial news and data tailored to specific country editions
